Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

58.44
+0.11000.19%
Volume:2.37M
Turnover:139.25M
Market Cap:14.48B
PE:18.38
High:59.27
Open:58.47
Low:57.88
Close:58.33
52wk High:61.14
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:1.08
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.85
PE(LYR):21.02

Loading ...

Exelixis (EXEL) Margin Expansion To 35.1% Challenges Bearish Pricing Narratives

Simply Wall St.
·
May 07

Exelixis, Inc. : H.c. Wainwright Raises Target Price to $56 From $54

THOMSON REUTERS
·
May 07

Exelixis price target raised to $50 from $49 at Morgan Stanley

TIPRANKS
·
May 07

Exelixis price target raised to $47 from $44 at Stifel

TIPRANKS
·
May 07

Stock Track | Exelixis Soars 9.32% Intraday on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 07

Exelixis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 07

Exelixis Seen Trading Steady on Modest Drug Growth, RBC Says

MT Newswires Live
·
May 07

Stock Track | Exelixis Soars 5.99% in Pre-market on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 06

Goldman Sachs Remains a Buy on Exelixis (EXEL)

TIPRANKS
·
May 06

Exelixis (EXEL) Gets a Hold from Wells Fargo

TIPRANKS
·
May 06

Exelixis Kept at Hold as Cabo Momentum Offsets Pipeline Uncertainty; Price Target Raised from $49 to $50

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)

TIPRANKS
·
May 06

Margin Gains From Oncology Portfolio Might Change The Case For Investing In Exelixis (EXEL)

Simply Wall St.
·
May 06

Exelixis Price Target Raised to $55 on Cabo Strength, Buyback-Driven EPS Growth, and Zanzalintinib Upside Optionality

TIPRANKS
·
May 06

Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Exelixis Posts Strong Q1 Results, Expands Share Buybacks

TIPRANKS
·
May 06

Exelixis Q1 revenue slightly beats estimates

Reuters
·
May 06

GUIDANCE: (EXEL) Exelixis Expects Full Year 2026 Revenue Range $2.53B - $2.63B, vs. FactSet Est of $2.58B

MT Newswires Live
·
May 06

Exelixis Q1 FY26 GAAP diluted EPS climbs to $0.79; revenue rises to $610.8 million

Reuters
·
May 06

Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate

Benzinga Earnings
·
May 06